Literature DB >> 620336

Papilloedema in patients taking perhexiline maleate.

W M Hutchinson, J Williams, J Gawler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 620336      PMCID: PMC1602721          DOI: 10.1136/bmj.1.6108.305-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Papilledema in the Guillain-Barré syndrome.

Authors:  A L DREW; K R MAGEE
Journal:  AMA Arch Neurol Psychiatry       Date:  1951-12

2.  [Peripheral neuropathies caused by perhexiline maleate. Apropos of 7 cases].

Authors:  M G Bousser; P Bouche; C Brochard; G Herreman
Journal:  Coeur Med Interne       Date:  1976 Apr-Jun

3.  Papilloedema and the Landry-Guillain-Barré syndrome. Case reports and a review.

Authors:  J B Morley; E H Reynolds
Journal:  Brain       Date:  1966-06       Impact factor: 13.501

  3 in total
  4 in total

1.  Polymorphic hydroxylation of perhexiline maleate in man.

Authors:  R G Cooper; D A Evans; E J Whibley
Journal:  J Med Genet       Date:  1984-02       Impact factor: 6.318

2.  Impaired oxidation of debrisoquine in patients with perhexiline neuropathy.

Authors:  R R Shah; N S Oates; J R Idle; R L Smith; J D Lockhart
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-30

3.  Papilloedema and hepatic dysfunction apparently induced by perhexiline maleate (Pexid).

Authors:  A B Atkinson; D McAreavey; G Trope
Journal:  Br Heart J       Date:  1980-04

Review 4.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.